Mindy Valcarcel is a copy editor at Healio. She focuses on themes related to medicine and healthcare, including medical specialties, alternative medicine, healthcare systems, diagnostics, and health and wellness. Mindy is featured in Healio, where she brings insights on various topics such as AI, Coronavirus, and global health issues across regions like Africa and Japan.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Mindy Valcarcel's coverage primarily focuses on healthcare, with a strong emphasis on citing data to support her articles. She frequently covers topics related to cancer treatment, pain management, and women in the medical profession.
Given Mindy's reliance on data-driven content, she would likely be receptive to pitches from experts and researchers who can provide insights backed by solid scientific or medical evidence. Additionally, professionals with firsthand experience in implementing innovative treatments or addressing challenges within the healthcare system may capture her interest.
As there is no specific geographic focus mentioned for Mindy's coverage, it appears that she takes a broad approach to healthcare topics without being confined to a particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Matthew Shinkle, Mindy Valcarcel
SAN DIEGO — Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings achieved worse survival outcomes than those who received the agents in pivotal trials.
By: Jayanth Sridhar, Mindy Valcarcel, Chirag P. Shah
As physicians, we have all borne witness to patients dying at a young age, whether from an unforeseen illness or injury.
By: Mindy Valcarcel, Jennifer Byrne
Key takeaways: Inferior vena cava filters are recommended for temporary use to prevent pulmonary embolism when anticoagulation is contraindicated.
By: Paolo Caimi, Mindy Valcarcel, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration
By: Paolo Caimi, Erin Michael, Mindy Valcarcel
SAN DIEGO — In this video, Paolo Caimi , MD, a physician and clinical investigator at Cleveland Clinic, discussed research on the use of bispecific antibodies for lymphoma presented at ASH Annual Meeting and Exposition.
By: Mindy Valcarcel, Josh Friedman
Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with HER2-positive breast cancer , according to long-term results of a randomized phase 3 trial.
By: Josh Friedman, Mindy Valcarcel
Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.
By: Mindy Valcarcel, Jennifer R. Southall
Latinas in the U.S. medical system experience disproportionate barriers and discriminatory behaviors from colleagues and patients, according to results of an online survey.
By: Mindy Valcarcel, Jennifer Byrne
Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society's chief scientific officer after more than a decade in the position.
By: Mindy Valcarcel, Josh Friedman
Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune response, according to updated results of a phase 1 trial.
(833) 317-6278 
